Award
NIH Reporter #5U01DK136965-04
Developing A Platform Technology For -Cell-Targeted Drug Delivery
Recipient
Stanford University
Award Amount
$552,414.00
Ceiling
$552,414.00
Awarded
August 10, 2026
Identifier
5U01DK136965-04
NIH grant awarded to Stanford University to develop a platform technology for targeted drug delivery to -cells for diabetes treatment, focusing on prodrug strategies for regenerative therapies.
Description
This project aims to develop a novel platform technology for -cell-targeted drug delivery to treat diabetes. The research focuses on creating a prodrug strategy that leverages the unique biological activity of -cells to convert latent prodrugs into bioactive compounds, enabling targeted and safe regenerative therapies.